ASHLEY BIGBY: Open Payments
NPI 1154053452 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 17 payments from 10 companies in 2025. Trend: 2023 $714 · 2024 $443 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $100 |
| Apellis Pharmaceuticals, Inc. | 2 | $41 |
| ANI Pharmaceuticals, Inc. | 2 | $41 |
| Vifor Pharma, Inc. | 2 | $40 |
| GENZYME CORPORATION | 1 | $34 |
| Novo Nordisk Inc | 1 | $27 |
| Travere Therapeutics, Inc. | 1 | $23 |
| SCPHARMACEUTICALS INC. | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: JYNARQUE, Empaveli, PURIFIED CORTROPHIN GEL, Veltassa, FABRAZYME, Rivfloza, FUROSCIX, ACTHAR.
Industry payments across MO — which companies pay providers there.
